4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Artelo Biosciences, Inc. (ARTL) operates in the Biotechnology industry and is headquartered in Solana Beach, United States with about 7 employees. Its market capitalization is roughly $4 million. In the fiscal year ended 2025-12-31, ARTL reported $0M in revenue and ($13M) in net income.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-08-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($11M) | ($10M) | ($10M) | ($10M) | — |
| Net Income | ($13M) | ($10M) | ($9M) | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($3M) | ($3M) | ($3M) | ($2M) | — |
| Net Income | ($3M) | ($4M) | ($3M) | ($3M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-08-31 |
|---|---|---|---|---|---|
| Total Assets | $3M | $5M | $13M | $20M | — |
| Total Liabilities | $4M | $2M | $1M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ARTL viewer.
About TickerBase · Data methodology & sources